Sol-gel polymer composites and uses thereof

Patent metadata

Field	Value
Publication number	US-10064870-B2
Application number	US-201615341028-A
Country	US
Kind code	B2
Filing date	Nov 2, 2016
Priority date	Nov 3, 2015
Publication date	Sep 4, 2018
Grant date	Sep 4, 2018

Abstract

The present disclosure relates generally to sol-gel polymer composites that comprise chitosan, a hydrophilic polymer, a gelation agent, and optional additional ingredients in a suitable medium. Advantageously, the sol-gel polymer composite can form a durable seal or strong solid in response to one or more physiological stimulus. The disclosure further relates to medical and veterinary uses of the composite, particularly, methods and delivery systems for reducing or preventing the incidence of a mammary disorder in a dairy animal. More particularly, the disclosure includes methods and sol-gel polymer composite compositions for creating a physical barrier on the teat surface or in the teat canal or cistern of a non-human animal for prophylactic treatment of mammary disorders such as mastitis wherein the sol-gel polymer creates a seal in response to one or more physiological stimulus.

First claim

What is claimed is:

1. A product for preventing or treating a mammary disorder in a female non-human animal, the product comprising an effective amount of a sol-gel polymer composite formed from a combination of:
chitosan;
a hydrophilic polymer comprising methylcellulose;
a gelation agent comprising a salt selected from the group consisting of sodium pyrophosphate tetrabasic, potassium phosphate dibasic trihydrate, and mixtures thereof; and
a suitable medium comprising an aqueous acid.

2. The product according to claim 1 , wherein the medium is aqueous acetic acid.

3. The product according to claim 1 , wherein the chitosan is acylated.

4. The product according to claim 3 , wherein the acylated chitosan is carboxymethyl chitosan.

5. The product according to claim 1 , wherein the sol-gel polymer composite further comprises a reinforcing agent.

6. The product according to claim 5 , wherein the reinforcing agent is selected from the group consisting of nanocrystalline cellulose, an inorganic clay, an organic clay, carbon black, fumed silica, graphene, graphite, a nanocrystalline starch, a nanoclay, graphene, a carbon nanotube, an organic nanoclay, an organoclay, montmorillonite, bentonite, kaolinite, hectorite, halloysite, and calcium phosphate.

7. The product according to claim 1 , wherein the sol-gel polymer composite further comprises one or more antimicrobial agents.

8. The product according to claim 7 , wherein the antimicrobial agent is selected from the group consisting of a macrolide, a cephalosporin, a lincosaminide antibiotic, a fluoroquinolone, a tetracycline, a penicillin, a spectinomycin, a sulfonamide, a chloramphenicol, a fluorinated synthetic analog of thiamphenicol and a mixture thereof.

9. The product according to claim 8 , wherein the antimicrobial agent is a cephalosporin and the cephalosporin is ceftiofur hydrochloride.

10. A method for treating a mammary disorder in a non-human animal in need thereof, the method comprising administering to the non-human animal the product of according to claim 1 , wherein the mammary disorder is mastitis.

11. The method according to claim 10 , wherein the method comprises dipping a teat of the non-human animal in the product.

12. The method according to claim 10 , wherein the method comprises intramammary infusion of the product.

13. The method according to claim 10 , wherein the animal is a dairy livestock animal.

14. The method according to claim 13 , wherein the livestock animal is a heifer, a cow, a goat, a sheep or a water buffalo.

15. A sol-gel polymer composite, wherein the sol-gel polymer composite is formed from a combination of:
chitosan;
a hydrophilic polymer comprising methylcellulose;
a gelation agent comprising a salt selected from the group consisting of sodium pyrophosphate tetrabasic, potassium phosphate dibasic trihydrate, and mixtures thereof; and
an acidic water-based medium,
wherein the sot-gel polymer composite is configured to be a strong solid at a temperature of about 37° C., said strong solid being evidenced by having an elastic modulus (G′) of about 450 Pa to about 10,000 Pa.

16. The sol-gel polymer composite according to claim 15 , wherein the chitosan is carboxymethyl chitosan.

17. The sol-gel polymer composite according to claim 15 , wherein the acidic water-based medium comprises 0.1M aqueous acetic acid.

Assignees

• Zoetis Services Llc

Inventors

• Rajagopalan Sumitra
• Baille Wilms
• Kujawa Piotr
• Zook Christopher A
• Quesnell Rebecca R
• Huczek Dennis L
• Secreast Stephen L
• Luo Laibin
• Sanders Tammy A

Classifications

• A61P31/00

  Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

• A61P15/14

  for lactation disorders, e.g. galactorrhoea · CPC title

• A61K47/36

  Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title

• A61K9/0024

  Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L) · CPC title

• A61K47/02

  Inorganic compounds · CPC title